Monogram Capital Partners Fund III closed at its $350 million hard cap, marking the firm’s largest fundraise to date and bringing total regulatory assets under management (RAUM) to approximately $1.75 billion. The fund was substantially oversubscribed, attracting commitments from existing limited partners (LPs) since the firm’s inception, alongside new institutional investors including endowments, foundations, family offices, and funds of funds.
Monogram Capital Partners, a Los Angeles-based private equity firm founded in 2014, specializes in building enduring consumer brands. Fund III represents a significant escalation from prior vehicles, underscoring investor confidence in the firm’s track record amid a competitive fundraising environment. The oversubscribed close at the hard cap highlights Monogram’s ability to deliver value in the consumer sector, where it acts as a bridge between family held businesses and institutional capital.
Monogram’s approach combines flexible capital with operational expertise to professionalize and grow portfolio companies. The firm typically enters as the first institutional investor in control or minority growth transactions, leveraging industry relationships to drive sustainable expansion.
Fund III builds on Monogram’s fundraising progression, demonstrating consistent growth and LP retention. The table below compares key metrics across the firm’s funds:
| Fund | Vintage Year | Size (Hard Cap) | Status | Key Notes |
| Fund I | 2018 | $152 million | Closed (2023 final close) | Oversubscribed debut; focused on emerging consumer/retail brands; commitments from endowments, foundations, and family offices. |
| Fund II | 2020 | $250 million | Closed | 40% larger than Fund I; invested in companies like Oatly Group; emphasized buyout strategy in consumer products. |
| Fund III | 2025 | $350 million | Closed (Nov 18, 2025) | Oversubscribed; largest to date; expands RAUM to $1.75B; new LPs and team growth initiatives. |
This trajectory reflects Monogram’s maturation, with each fund roughly 40-60% larger than the prior, driven by strong performance in prior vintages, including a recent exit from Western Smokehouse.
Monogram Capital Partners’ closure of its third fund at $350 million exemplifies the firm’s evolution from a niche consumer investor to a scaled platform managing $1.75 billion in RAUM. Established in 2014 by Jared Stein and Oliver Nordlinger in Los Angeles, Monogram has consistently targeted lower middle market opportunities in consumer and retail ecosystems, distinguishing itself through a founder friendly model that prioritizes cultural preservation alongside growth. This latest milestone arrives at a pivotal moment for the sector, where investor appetite for resilient consumer plays remains strong despite macroeconomic headwinds like elevated interest rates and shifting consumer spending patterns.
The oversubscription of Fund III, closing at its hard cap after drawing broad institutional interest, reflects Monogram’s proven ability to generate returns in a crowded field. Returning LPs, who have backed the firm since its $152 million debut in 2018, were joined by newcomers from endowments, foundations, family offices, and funds of funds, creating a diversified base resilient to sector specific volatility. Placement agent Lazard’s involvement streamlined the process, while Latham & Watkins ensured seamless legal execution. This composition not only validates Monogram’s track record, including investments in high profile names like Oatly, but also positions the firm for enhanced co-investment opportunities and broader deal access.
At its core, Monogram’s strategy revolves around four synergistic verticals, each leveraging macro trends for outsized growth potential. In food & beverage, the firm eyes scalable brands amid a push toward sustainable, premium products; beauty & personal care capitalizes on wellness booms and clean label innovations; the pet sector benefits from post pandemic pet humanization, with U.S. spending projected to exceed $150 billion by 2030; and consumer/business services target enablers like logistics firms adapting to omnichannel retail. This focused thesis, executed via control buyouts or minority stakes, has historically delivered through operational interventions, such as supply chain optimization and go to market refinements, yielding enduring category leaders.

Recommended: An Interview With Joseph Barrato, CEO Of Arrow Funds
Comparatively, Fund III’s 40% size increase over the $250 million Fund II (closed around 2020) mirrors Monogram’s fundraising cadence: rapid cycles (2-3 years between closes) fueled by quick capital deployment and exits. Fund I’s oversubscription set the tone, securing high caliber LPs early and establishing a benchmark for thesis driven investing. PitchBook data confirms Fund II’s buyout focus, with deployments like Oatly underscoring consumer product prowess. Post Fund III, RAUM growth to $1.75 billion enhances bargaining power in auctions and supports larger ticket sizes ($20-50 million per deal), potentially shortening hold periods to 4-6 years.
Operationally, the fundraise enables platform maturation. Stein’s vision of Monogram as a “bridge” to institutional capital emphasizes empathetic scaling, preserving family legacies while injecting professional governance. Nordlinger’s focus on institutionalization includes recruiting sector specialists and scaling the operating partner network, veterans from brands like Procter & Gamble or Unilever, to embed expertise in portfolio companies. This layered approach mitigates execution risks, as evidenced by recent activities: the March 2025 investment in Tartine Bakery expands bakery holdings with a premium, artisanal angle, while the February exit from Vessel (a consumer wellness play) generated liquidity for LPs.
In market context, Fund III’s timing aligns with PE’s consumer rebound. Post 2022 slowdowns, deal volumes in food/beauty/pet have surged 15-20% year over year, per Bain & Company insights, driven by private label resilience and e-commerce penetration. Monogram’s supply chain tilt hedges inflation, targeting service providers with 10-15% EBITDA margins. Risks include raw material volatility and regulatory scrutiny on consumer health claims, but the firm’s long term horizon (7-10 year fund life) buffers these. Implications for stakeholders: LPs gain exposure to a high conviction sector with 15-20% targeted IRRs; founders access patient capital without loss of control; and the broader ecosystem sees accelerated innovation in everyday consumer touchpoints.
Looking ahead, Fund III could catalyze 10+ deals, prioritizing U.S. centric opportunities with international upside (e.g., exporting pet brands to Europe). Monogram’s 36+ investments and 4 exits to date, coupled with recent Western Smokehouse divestiture, affirm a 1.5-2x multiple potential. As consumer PE consolidates, Monogram’s specialized footprint likely attracts acquisition interest from larger GPs, though its independent trajectory suggests multi fund ambitions. Ultimately, this close reinforces Monogram’s mandate: fostering businesses that endure, delivering value across the consumer value chain.
Please email us your feedback and news tips at hello(at)superbcrew.com
Activate Social Media:
